Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

Type III hyperlipoproteinemia is characterized by delayed chylomicron and VLDL remnant catabolism and is associated with homozygosity for the apoE-2 allele. We have identified a kindred in which heterozygosity for an apoE mutant, apoE-1 (Lys146-->Glu), is dominantly associated with the expression of...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Mann, W A, Lohse, P, Gregg, R E, Ronan, R, Hoeg, J M, Zech, L A, Brewer, H B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185299/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7635945/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118096
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!